Page 26 - Htain Manual
P. 26

H
                                 ealth  policy  decisions  are  becoming  increasingly  important  as  the

                                 opportunity costs of making wrong decisions continue to grow, especially

                                 in countries where health sector is underfunded. A finite health budget

               means that policy makers are faced with difficult decisions regarding choice of technology
               and prioritisation of health services on a daily basis.


                       For example should government introduce a new point of care diagnostic for a fever

               or measuring anaemia, which would cost higher per test, but is more specific or accurate. Is

               the increase in accuracy and ease of diagnosis worth the much higher spend that government
               would have to undertake. Or for cataract surgery should the insurance scheme reimburse for

               extra capsular surgery or only for cryosurgery or both, though there is a wide degree in costs

               between the two procedures?


                       Another  set  of  questions  relates  to  programme  design.  For  example,  should
               government limit screening for oral cancers or hypertension to only those who come to a

               health facility, or should there be an effort to actively screen everyone in the population.

               Should periodic screening for breast cancer be offered annually to all above 30 or is it better
               to offer once in three years to those above 45 years only.


                       At a more complex level, when government plays the role of strategic purchaser of

               healthcare,    policy-makers  would  be  confronted  with  many  decisions  of  which  health

               condition  and  population  are  be  prioritised  for  purchase  and  why.    For  example,  the
               government may be sanctioned some additional resources and have to decide whether to

               spend it on reimbursement of those being treated with renal dialysis in elderly with chronic

               renal illness or for treating  children with leukemia or for diagnosing and treating patients

               chronic hepatitis?  One woman with breast cancer may be treated with chemotherapy for the

               same cost as treating 20 lakh children for intestinal worms.

                       Health  Technology  Assessment  (HTA)  offers  scientific  solutions  to  such  complex

               problems and assists policy makers in taking transparent and prudent decisions. In order to

               solve such issues in a judicious manner, HTA is a widely used methodology internationally for

               optimization  of  resource  allocation  in  health.  Employing  a  scientific  and  evidence  based
               methodology, HTA assists in judicious choice of technology and programme design and in the

               financial  allocations  so  that  maximum  people  can  have  access  to  quality  healthcare  at



                                                           14
   21   22   23   24   25   26   27   28   29   30   31